Finance

Lists
Why is VERA down 2.34%?
Dive Deeper
VERA:NASDAQ
Vera Therapeutics, Inc
$28.36
-2.34%
(-0.68) 1D
Nov 13, 1:21:42 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VERA...
Open
$28.64
High
$28.96
Low
$27.85
Mkt. cap
2.05B
Avg. vol.
1.71M
Volume
297.44K
52-wk high
$56.04
52-wk low
$26.38
EPS
-$5.90
Beta
1.07
Shares outstanding
72.30M
No. of employees
362
Open
$28.64
High
$28.96
Low
$27.85
Mkt. cap
2.05B
Avg. vol.
1.71M
Volume
297.44K
52-wk high
$56.04
52-wk low
$26.38
EPS
-$5.90
Beta
1.07
Shares outstanding
72.30M
No. of employees
362
News stories
From web sources and news partners
About Vera Therapeutics, Inc
CEO-
Employees362
Founded2016
HeadquartersBrisbane, California, United States
SectorHealth Care
IndustryBiotechnology
Websiteveratx.com
Analyst ratings
Based on 13 analysts giving stock ratings to VERA in the past 3 months
Strong buy
Buy
11
Hold
2
Sell
0
12-month forecast
Based on 13 Wall Street analysts offering 12 month price targets for VERA in the last 3 months.
Highest
Current $28.36
$100.00 (+252.61%)
Average
$68.73 (+142.35%)
Lowest
$29.00 (+2.26%)
Analyst
Recommendation
Action
Price target
Projected
Date
Anupam Rama
J.P. Morgan
Buy
Maintained
$75.00
+164.5%
11/12/2026
Dina Ramadane
Bank of America Securities
Buy
Maintained
-
-
11/06/2026
Laura Chico
Wedbush
Hold
Maintained
$29.00
+2.3%
11/06/2026
Pete Stavropoulos
Cantor Fitzgerald
Buy
Maintained
$100.00
+252.6%
11/05/2026
Vamil Divan
Guggenheim
Buy
Reiterated
$66.00
+132.7%
11/05/2026
Arthur He CFA
H.C. Wainwright
Buy
Reiterated
$75.00
+164.5%
11/06/2026
Will Soghikian
Leerink Partners
Hold
Maintained
$34.00
+19.9%
10/27/2026
Unknown Analyst
Leerink Partners
Hold
Maintained
$34.00
+19.9%
10/27/2026
Paul Choi
Goldman Sachs
Buy
Reiterated
$80.00
+182.1%
10/22/2026
Mohit Bansal
Wells Fargo
Buy
Maintained
$70.00
+146.8%
10/15/2026
Unknown Analyst
Jefferies
Buy
Maintained
$59.00
+108%
09/16/2026
Rami Katkhuda
LifeSci Capital
Buy
Maintained
$90.00
+217.3%
09/15/2026
Ryan Deschner
Raymond James
Buy
Maintained
-
-
09/15/2026
Ritu Baral
TD Cowen
Buy
Maintained
$78.00
+175%
08/31/2026
Gavin Clark-Gartner
Evercore ISI
Buy
Maintained
$91.00
+220.9%
07/09/2026
Unknown Analyst
Wells Fargo
Buy
Maintained
$70.00
+146.8%
06/11/2026
Andy Chen
Wolfe Research
Buy
Maintained
$88.00
+210.3%
06/02/2026
Unknown Analyst
Wedbush
Hold
Maintained
$35.00
+23.4%
05/08/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
-
-
-
10.28M
Cost of goods sold
-
-
-
3.30M
Cost of revenue
-
-
-
3.30M
Research and development expenses
59.31M
86.01M
60.08M
41.25M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
34.90M
39.12M
52.41M
61.43M
Operating expense
94.21M
125.13M
112.49M
102.68M
Total operating expenses
94.21M
125.13M
112.49M
105.98M
Operating income
-94.21M
-125.13M
-112.49M
-95.70M
Other non operating income
-303.00K
-32.00K
-483.00K
-472.00K
EBT including unusual items
-91.10M
-121.03M
-109.47M
-93.71M
EBT excluding unusual items
-90.90M
-120.63M
-109.47M
-93.71M
Income tax expense
1.00K
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-91.10M
-121.03M
-109.47M
-93.71M
Net profit margin
-
-
-
-911.85%
Earnings per share
-1.39
-1.69
-1.52
-1.30
Interest and investment income
5.52M
6.36M
5.35M
4.34M
Interest expense
-1.90M
-1.82M
-1.85M
-1.87M
Net interest expenses
3.61M
4.53M
3.50M
2.46M
Depreciation and amortization charges
-
-
-
-
EBITDA
-94.07M
-124.99M
-112.36M
-94.88M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps